Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Abstract

Economic and disease reduction benefits would be realized from the use of an RV vaccine that is partially protective against severe RV diarrhea. These findings suggest that immunization with an RV vaccine would be cost effective and cost saving.